Nasdaq cprx.
Selling, general and administrative expenses totaled $14.7 million, up from $13.2 million reported in the year-ago quarter. As of Dec 31, 2022, CPRX had cash, cash equivalents and investments ...
Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.The stock of Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) has increased by 5.94 when compared to last closing price of 12.63.Despite this, the company has seen a gain of 4.12% in its stock price over the last five trading days. Zacks Investment Research reported 2023-11-09 that Catalyst (CPRX) reports mixed third-quarter results.Aug 27, 2022 · Anyone interested in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) should probably be aware that the Chief Commercial Officer, Jeffrey Del Carmen, recently divested US$199k worth of shares in the ... Shareholders of Catalyst Pharmaceuticals ( CPRX -1.13%) got a nasty shock on Jan. 23 when the company reported that a competitor, Teva Pharmaceutical Industries ( TEVA -1.12%), was planning to ...
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is a Florida-based commercial-stage biopharmaceutical company, focused on developing and commercializing therapies for patients with rare debilitating ...Stock analysis for Catalyst Pharmaceuticals Inc (CPRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is a Florida-based commercial-stage biopharmaceutical company that focuses on therapies for rare debilitating, chronic neuromuscular, and neurological ...
Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Catalyst Pharmaceuticals CPRX stock has skyrocketed 80.6% in the year-to-date period against the industry’s decline of 28.5%. ... The Top 10 Constituents of the Nasdaq-100 Index Aug 26, 2022;
That number of contracts represents approximately 900,900 underlying shares, working out to a sizeable 56.5% of CPRX's average daily trading volume over the past month, of 1.6 million shares.Discover historical prices for PCRX stock on Yahoo Finance. View daily, weekly or monthly format back to when Pacira BioSciences, Inc. stock was issued.Find the latest SEC Filings data for Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) at Nasdaq.com.Dec 12, 2022 · Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is a Florida-based commercial-stage biopharmaceutical company that focuses on therapies for rare debilitating, chronic neuromuscular, and neurological ... For the last reported quarter, Catalyst came out with earnings of $0.20 per share versus the Zacks Consensus Estimate of $0.19 per share, representing a surprise of 5.26%. For the previous quarter ...
Catalyst Pharmaceuticals (NASDAQ:CPRX) Insider Buying and Selling Activity. Current Insider Ownership Percentage 12.10%. Number Of Insiders Buying (Last 12 Months) 0. Number Of Insiders Selling (Last 12 Months) 6. Amount Of Insider Selling (Last 12 Months) $4.07 M. Get CPRX Insider Trade Alerts.
Find the latest Revenue & EPS data for Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) at Nasdaq.com.
Catalyst Pharmaceuticals, Inc. (CPRX.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Catalyst Pharmaceuticals, ...Catalyst Pharmaceuticals ( NASDAQ: CPRX) is a commercial-stage biopharmaceutical entity dedicated to in-licensing, developing, and marketing novel treatments for rare and challenging diseases ...A high-level overview of Catalyst Pharmaceuticals, Inc. (CPRX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Crypto Sectors U.S. markets closed +26.83 +78.81 Russell 2000 +53.62(+2.96%) Crude Oil -1.58(-2.08%) Gold +34.50(+1.68%) Catalyst Pharmaceuticals, Inc. (CPRX) NasdaqCM - NasdaqCM Real Time... Catalyst Pharmaceutical (CPRX) closed at $15.25 in the latest trading session, marking a -1.74% move from the prior day. This move was narrower than the S&P 500's daily loss of 2%.Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with..Feb 27, 2023 · For the last reported quarter, Catalyst came out with earnings of $0.20 per share versus the Zacks Consensus Estimate of $0.19 per share, representing a surprise of 5.26%. For the previous quarter ...
Find the latest Revenue & EPS data for Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) at Nasdaq.com.Nov 30, 2023 · NASDAQ:CPRX - Catalyst Pharmaceuticals Stock Price, News & Analysis Should You Buy or Sell Catalyst Pharmaceuticals Stock? Get The Latest CPRX Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. Should You Buy or Sell Catalyst Pharmaceuticals Stock? Per the terms of the agreement, CPRX is liable to make an upfront payment of $75 million to Santhera, along with a concurrent strategic equity investment of $15 million into Santhera.CORAL GABLES, Fla., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced the appointment of Michael W. Kalb as its Executive ...Find the latest historical data for Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) at Nasdaq.com.Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock ...
Crypto Sectors U.S. markets closed +26.83 +78.81 Russell 2000 +53.62(+2.96%) Crude Oil -1.58(-2.08%) Gold +34.50(+1.68%) Catalyst Pharmaceuticals, Inc. (CPRX) NasdaqCM - NasdaqCM Real Time...This is my fifth Catalyst (NASDAQ:CPRX) article following 04/2023's "Catalyst Pharmaceuticals: Fixing Its Misnomer Is No Easy Task". My concern with Catalyst is expressed as, "I have long chafed ...
Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Catalyst Pharmaceuticals, Inc. (CPRX.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Catalyst Pharmaceuticals, ...Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. Turning to the calls side of the option chain, the call contract at the $15.00 strike price has a current bid of $1.70. If an investor was to purchase shares of CPRX stock at the current price ...The $210.13 million and $294.89 million estimates for the current and next fiscal years indicate changes of +49.2% and +40.3%, respectively. Catalyst reported revenues of $57.24 million in the ...Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) Q1 2023 Earnings Conference Call May 11, 2023 8:30 AM ETCompany Participants. Patrick McEnany - Chairman, Chief Executive Officer. Alicia Grande - Vice ...See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. CPRX's current price target is $24.75. Learn why top …Catalyst Pharmaceuticals last released its quarterly earnings data on November 8th, 2023. The biopharmaceutical company reported ($0.26) earnings per share for the quarter, hitting the consensus estimate of ($0.26). The business earned $102.69 million during the quarter, compared to the consensus estimate of $100.17 million.
CORAL GABLES, Fla., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced the appointment of Michael W. Kalb as its Executive ...
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is a Florida-based commercial-stage biopharmaceutical company that focuses on therapies for rare debilitating, chronic neuromuscular, and neurological ...
You can take a look at the company's revenue and earnings growth trend, in the chart below. To see the actual numbers, click on the chart. NasdaqCM:CPRX Earnings and Revenue History July 30th 2021Common Stock, par value $0.001 per share CPRX NASDAQ Capital Market Securities registered pursuant to Section 12(g) of the Act.: None Indicate by check mark if registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒CORAL GABLES, Fla., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announced that it has successfully completed …Mar 16, 2023 · Catalyst Pharmaceuticals, Inc. CPRX reported earnings of 22 cents per share for the fourth quarter of 2022, marginally beating the Zacks Consensus Estimate of 21 cents. Earnings were also higher ... Catalyst Pharmaceuticals (NASDAQ:CPRX) has recently experienced a trading halt on the Nasdaq exchange, leaving investors eagerly awaiting pending news. The specific cause for this halt remains undisclosed, however, it is widely anticipated that it revolves around the potential disclosure of significant information.CPRX CPRX AFTER HOURS QUOTE CPRX LATEST AFTER HOURS TRADES. ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Stocks, Funds, ...(CPRX). NASDAQ: CPRX · IEX Real-Time Price · USD. Add to Watchlist. 14.06. +0.20 (1.44%). At close: Nov 24, 2023, 1:00 PM. 13.82. -0.24 (-1.71%). After-hours: ...Find the latest press releases from Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) at Nasdaq.com.U.S. FDA Assigned Target Action Date of June 4, 2024. CORAL GABLES, Fla., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced ...
Based in Coral Gables, Florida, Catalyst Pharmaceuticals (NASDAQ:CPRX) is a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people ...Shares of NASDAQ:CPRX opened at $14.82 on Monday. The stock has a market capitalization of $1.58 billion, a price-to-earnings ratio of 28.50 and a beta of 1.11. …Catalyst Pharmaceuticals, Inc. (CPRX) NasdaqCM - NasdaqCM Real Time Price. Currency in USD. Follow. 2W 10W 9M. 14.82 +0.39 (+2.70%) At close: 04:00PM EST. 14.85 +0.03 …Instagram:https://instagram. is thimble insurance legitbest affordable health insurance for young adultsindependent contractor tax software2023 dividend aristocrats A commercial-stage biopharmaceutical firm, Catalyst Pharmaceuticals (NASDAQ:CPRX) focuses on developing and commercializing innovative therapies for people with rare debilitating, chronic ... afslstock it Aug 9, 2023 · CORAL GABLES, Fla., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “the Company”) (Nasdaq: CPRX) today reported financial results for the second quarter of 2023 and provided a corporate update. Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton … best sandp mutual funds Catalyst Pharmaceutical (CPRX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance ...This value model looks for companies with high return on capital and earnings yields. CATALYST PHARMACEUTICALS INC ( CPRX) is a small-cap value stock in the Biotechnology & Drugs industry. The ...Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) dropped 7.5% during mid-day trading on Friday . The company traded as low as $12.43 and last traded at $12.43. Approximately ...